Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment. It exhibits high efficacy, with IC 50 values of 8.19 nM and 9.99 nM for PDE9A1 and PDE9A2, respectively [1].
Molecular Weight:
394.47
Purity:
98.14%
CAS Number:
[2062661-53-2]
Formula:
C21H26N6O2
Target:
PDE
T61833
* VAT and and shipping costs not included. Errors and price changes excepted